A clinical study of cancer peptides vaccine therapy using URLC10, CDCA1, and KOC1-targeted peptides in the patients who had no more treatment against oral cancer
Phase 1
Recruiting
- Conditions
- oral cancer
- Registration Number
- JPRN-UMIN000008379
- Lead Sponsor
- Department of Oral and Maxillofacial surgery, Graduated school of medicine Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnancy or lactation. 2. Patients who are treated with steroid or immunotherapy during clinical trial. 3. Patients have uncontrollable associated cancer. 4. Patients who are not agree. 5. Patients who are inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safty
- Secondary Outcome Measures
Name Time Method immunological response and clinical efficacy